These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9707961)

  • 1. Withdrawal syndrome associated with abrupt discontinuation of SSRIs.
    Wincor MZ
    J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation symptoms and SSRIs.
    Pollock BG
    J Clin Psychiatry; 1998 Oct; 59(10):535-7. PubMed ID: 9818635
    [No Abstract]   [Full Text] [Related]  

  • 5. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of disequilibrium and nausea in the SRI discontinuation syndrome.
    Schechter JO
    J Clin Psychiatry; 1998 Aug; 59(8):431-2. PubMed ID: 9721826
    [No Abstract]   [Full Text] [Related]  

  • 7. A possible explanation for dizziness following SSRI discontinuation.
    Smith PF; Darlington CL
    Acta Otolaryngol; 2010 Sep; 130(9):981-3. PubMed ID: 20144124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer antidepressants and the discontinuation syndrome.
    Haddad P
    J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome.
    Haddad PM; Dursun SM
    Can J Psychiatry; 2004 May; 49(5):343-4; author reply 345-6. PubMed ID: 15198473
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.
    Polimeni G; Grugno R; Cordici F; Vitetta A; Caputi AP; Bramanti P
    J Clin Psychopharmacol; 2008 Oct; 28(5):589-91. PubMed ID: 18794668
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin discontinuation syndrome: does it really exist?
    Nuss S; Kincaid CR
    W V Med J; 2000; 96(2):405-7. PubMed ID: 10771628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
    Frost L; Lal S
    Am J Psychiatry; 1995 May; 152(5):810. PubMed ID: 7726327
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation reactions associated with SSRIs.
    Macdonald L
    CMAJ; 1998 Oct; 159(7):846-7; 850-2. PubMed ID: 9805037
    [No Abstract]   [Full Text] [Related]  

  • 18. [Paroxetine withdrawal syndrome].
    Belloeuf L; Le Jeunne C; Hugues FC
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A52-3. PubMed ID: 10855379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine discontinuation syndrome in association with sertindole therapy.
    Walker-Kinnear M; McNaughton S
    Br J Psychiatry; 1997 Apr; 170():389. PubMed ID: 9246265
    [No Abstract]   [Full Text] [Related]  

  • 20. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.